February 8, 2024
On January 9, 2024, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) announced a Final Rule, entitled Safeguarding the Rights of Conscience as Protected by Federal [...]
June 23, 2023
FTLF partners Molly S. Evans and Dianne K. Pledgie will speak during the 2023 Region IX Clinical Excellence and Leadership Conference, hosted by the California Primary Care Association and Western Clinicians Network. [...]
June 16, 2023
On February 2, 2023, the Health Resources and Services Administration (HRSA) published Program Assistance Letter (PAL) 2023-01, Calendar Year 2024 Requirements for Federal Tort Claims Act (FTCA) Coverage for Health Centers and [...]
June 8, 2023
Today the Supreme Court upheld long-standing precedent that protects the right to file suit in federal court against State and local agencies whose practices violate rights supplied by the U.S. Constitution and [...]
May 25, 2023
FTLF attorneys Nicole M. Bacon, Kathryn E. Doi, Susannah Vance Gopalan and Edward "Ted" Waters will speak at the California Primary Care Association (CPCA) Billing Managers Conference and CFO Conference from May 31 [...]
May 24, 2023
On May 10, the U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) announced it had entered into a Voluntary Resolution Agreement with Florida-based FQHC, MCR Health Inc. (MCR), [...]
May 8, 2023
Health center Federal Tort Claims Act (FTCA) annual redeeming applications are due by June 23, 2023. The requirements for redeeming for CY 2024 are described in Program Assistance Letter 2023-01 (PAL 2023-01), [...]
March 29, 2023
On February 17, 2023, the HHS Office for Civil Rights (OCR) released its Annual Report to Congress on Breaches of Unsecured Protected Health Information for Calendar Year 2021 (“HIPAA Breach Report”) and [...]
March 23, 2023
On March 8, 2023, the Health Resources and Services Administration (“HRSA”) updated its resource, Health Center Program FAQs, to include new and modified FAQs related to the Health Center Program, with a [...]
February 1, 2023
The United States Court of Appeals for the Third Circuit ruled on Monday in favor of drug manufacturers AstraZeneca, Sanofi and Novo Nordisk in their challenge against attempts by the Health Resources [...]